Board of Trustees
Board of Directors
November 6, 2024
Page 4
Valuation Conclusion
Based on the foregoing, it is our opinion that, as of November 6, 2024, the estimated aggregate pro forma market value of the shares to be issued immediately following the minority stock offering, both shares issued publicly as well as to the MHC, equaled $71,428,570 at the midpoint, equal to 7,142,857 shares offered at a per share value of $10.00. Pursuant to conversion guidelines, the 15% offering range indicates a minimum value of $60,714,280 and a maximum value of $82,142,860. Based on the $10.00 per share offering price determined by the Board, this valuation range equates to total shares outstanding of 6,071,428 at the minimum and 8,214,286 at the maximum. In the event the appraised value is subject to an increase, the aggregate pro forma market value may be increased up to a super maximum value of $94,464,290 without a resolicitation. Based on the $10.00 per share offering price, the super maximum value would result in total shares outstanding of 9,446,429. The Board of Directors has established a public offering range such that the public ownership of the Company will constitute a 43.0% ownership interest prior to the issuance of shares to the Foundation. Accordingly, the offering to the public of the minority stock will equal $26,107,150 at the minimum, $30,714,290 at the midpoint, $35,321,430 at the maximum and $40,619,640 at the super maximum of the valuation range. Based on the $10.00 offering price per share, the shares offered in the public offering are 2,610,715 at the minimum, 3,071,429 at the midpoint, 3,532,143 at the maximum and 4,061,964 at the super maximum. The number of shares issued to the Foundation are 121,428 at the minimum, 142,857 at the midpoint, 164,286 at the maximum and 188,929 at the super maximum. Based on the public offering range and inclusive of the shares issued to the Foundation, equal to 2.0% of the shares issued in the stock issuance, the public ownership of shares will represent 45.0% of the shares issued throughout the valuation range.
Limiting Factors and Considerations
The valuation is not intended, and must not be construed, as a recommendation of any kind as to the advisability of purchasing shares of the common stock. Moreover, because such valuation is determined in accordance with applicable regulatory guidelines and is necessarily based upon estimates and projections of a number of matters, all of which are subject to change from time to time, no assurance can be given that persons who purchase shares of common stock in the stock offering will thereafter be able to buy or sell such shares at prices related to the foregoing valuation of the estimated pro forma market value thereof. The appraisal reflects only a valuation range as of this date for the pro forma market value of Winchester Bancorp immediately upon issuance of the stock and does not take into account any trading activity with respect to the purchase and sale of common stock in the secondary market on the date of issuance of such securities or at anytime thereafter following the completion of the stock offering.
RP Financial’s valuation was based on the financial condition and operations of Winchester Savings as of September 30, 2024, the date of the financial data included in the prospectus.
RP Financial is not a seller of securities within the meaning of any federal and state securities laws and any report prepared by RP Financial shall not be used as an offer or solicitation with respect to the purchase or sale of any securities. RP Financial maintains a policy which prohibits RP Financial, its principals or employees from purchasing stock of its client institutions.